CERT
Certara, Inc.
- Latest sale
- $559k
- Sep 9 · Routine
- Form 4 sales
- 100
- On record
- Form 144 notices
- 7
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineFeb 12 2024
Sold 6,000 shares at $18.00 ($108k)
Traynor Richard M., SVP AND GENERAL COUNSEL
10b5-1 planSold 3.5% of holdings ($3.1M position)165,368 shares left1.1x usual sizeFiling
- 2 Form 4 saleRoutineFeb 20 +8 days
Sold 5,000 shares at $18.00 ($90k)
Smith Patrick F, PRESIDENT, DRUG DEV SOLUTIONS
10b5-1 planSold 8.3% of holdings ($1.1M position)54,975 shares left0.5x usual sizeFiling
- 3 Form 4 saleRoutineMar 4 +13 days
Sold 3,000 shares at $18.28 ($55k)
Traynor Richard M., SVP AND GENERAL COUNSEL
10b5-1 planSold 1.8% of holdings ($3M position)162,368 shares left0.5x usual sizeFiling
- 4 Form 4 saleRoutineApr 1 +28 days
Sold 3,000 shares at $18.00 ($54k)
Traynor Richard M., SVP AND GENERAL COUNSEL
10b5-1 planSold 1.7% of holdings ($3.2M position)173,524 shares left0.5x usual sizeFiling
- 5 Form 4 saleRoutineApr 2 +1 day
Sold 14,427 shares at $16.85 ($243k)
Smith Patrick F, PRESIDENT, DRUG DEV SOLUTIONS
10b5-1 planSold 22.4% of holdings ($1.1M position)50,091 shares left1.9x usual sizeFiling
- 6 Form 4 saleRoutineSep 9 +160 days
Sold 51,224 shares at $11.29 ($578k)
Pedersen Leif E, PRESIDENT, CHIEF COMMERCAL OFF
10b5-1 planSold 33.9% of holdings ($1.7M position)99,704 shares leftFiling
- 7 Form 4 saleRoutineOct 7 +28 days
Sold 5,409 shares at $11.03 ($60k)
Smith Patrick F, PRESIDENT, DRUG DEV SOLUTIONS
10b5-1 planSold 9.7% of holdings ($612k position)50,091 shares left0.6x usual sizeFiling
- 8 Form 4 saleRoutineSep 9 +337 days
Sold 51,224 shares at $10.92 ($559k)
Pedersen Leif E, PRESIDENT, CHIEF COMMERCAL OFF
10b5-1 planSold 40.9% of holdings ($1.4M position)73,979 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (107)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Form 4 sale | 51,224 | $559k | 40.9% | Routine | SEC |
| Oct 7, 2024 | Smith Patrick F | PRESIDENT, DRUG DEV SOLUTIONS | Form 4 sale | 5,409 | $60k | 9.7% | Routine | SEC |
| Sep 9, 2024 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Form 4 sale | 51,224 | $578k | 33.9% | Routine | SEC |
| Apr 2, 2024 | Smith Patrick F | PRESIDENT, DRUG DEV SOLUTIONS | Form 4 sale | 14,427 | $243k | 22.4% | Routine | SEC |
| Apr 1, 2024 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $54k | 1.7% | Routine | SEC |
| Mar 4, 2024 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $55k | 1.8% | Routine | SEC |
| Feb 20, 2024 | Smith Patrick F | PRESIDENT, DRUG DEV SOLUTIONS | Form 4 sale | 5,000 | $90k | 8.3% | Routine | SEC |
| Feb 12, 2024 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 6,000 | $108k | 3.5% | Routine | SEC |
| Feb 12, 2024 | Traynor Richard M. | Officer | Form 144 notice | 6,000 | $108k | Notice | SEC | |
| Dec 26, 2023 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 6,000 | $108k | 3.4% | Routine | SEC |
| Dec 26, 2023 | Traynor Richard M. | Officer | Form 144 notice | 6,000 | $108k | Notice | SEC | |
| Sep 11, 2023 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | Form 4 sale | 51,224 | $748k | 28.4% | Routine | SEC |
| Sep 11, 2023 | Pedersen Leif E | Officer | Form 144 notice | 51,224 | $748k | Notice | SEC | |
| Jun 5, 2023 | Smith Patrick F | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 19,104 | $412k | 24.2% | Routine | SEC |
| Jun 5, 2023 | Smith Patrick F | Officer | Form 144 notice | 19,104 | $412k | Notice | SEC | |
| May 11, 2023 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 5,000 | $104k | 2.7% | Routine | SEC |
| May 11, 2023 | Traynor Richard M. | Officer | Form 144 notice | 5,000 | $104k | Notice | SEC | |
| Apr 14, 2023 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 5,000 | $118k | 2.7% | Routine | SEC |
| Apr 14, 2023 | Traynor Richard M. | Officer | Form 144 notice | 5,000 | $118k | Notice | SEC | |
| Mar 6, 2023 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 10,000 | $215k | 5.1% | Plan not stated | SEC |
| Mar 6, 2023 | Traynor Richard M. | Officer | Form 144 notice | 10,000 | $215k | Notice | SEC | |
| Feb 2, 2023 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 15,000 | $300k | 7.2% | Unusual | SEC |
| Dec 8, 2022 | EQT Fund Management S.a r.l. | 10% owner | Form 4 sale | 30M | $449M | 100.0% | Unusual | SEC |
| Nov 22, 2022 | Pedersen Leif E | PRESIDENT, SOFTWARE | Form 4 sale | 51,223 | $797k | 22.6% | Plan not stated | SEC |
| Nov 15, 2022 | Slaine Mason P | Director | Form 4 sale | 250,000 | $3.9M | 27.5% | Unusual | SEC |
| Nov 14, 2022 | Walsh Matthew M | Director | Form 4 sale | 12,059 | $178k | 6.7% | Plan not stated | SEC |
| Nov 9, 2022 | Smith Patrick F | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 2,387 | $32k | 3.1% | Plan not stated | SEC |
| Aug 16, 2022 | Smith Patrick F | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 10,000 | $177k | 11.3% | Plan not stated | SEC |
| Aug 16, 2022 | EQT Avatar Parent GP LLC | 10% owner | Form 4 sale | 6M | $104M | 16.7% | Plan not stated | SEC |
| Aug 16, 2022 | Slaine Mason P | Director | Form 4 sale | 182,475 | $3.2M | 16.7% | Plan not stated | SEC |
| Jun 8, 2022 | Smith Patrick F | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 10,000 | $192k | 10.2% | Plan not stated | SEC |
| Jun 2, 2022 | Slaine Mason P | Director | Form 4 sale | 250,000 | $4.9M | 18.6% | Plan not stated | SEC |
| May 31, 2022 | EQT Avatar Parent L.P. | 10% owner | Form 4 sale | 1.5M | $28.5M | 4.0% | Plan not stated | SEC |
| Apr 4, 2022 | Smith Patrick F | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 3,352 | $75k | 3.3% | Plan not stated | SEC |
| Mar 17, 2022 | Slaine Mason P | Director | Form 4 sale | 250,000 | $5.1M | 15.7% | Unusual | SEC |
| Mar 16, 2022 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $60k | 1.4% | Plan not stated | SEC |
| Mar 16, 2022 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 62,485 | $1.3M | 2.8% | Plan not stated | SEC |
| Mar 11, 2022 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 27,515 | $558k | 1.2% | Plan not stated | SEC |
| Feb 18, 2022 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $1.8M | 3.2% | Plan not stated | SEC |
| Feb 17, 2022 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 90,000 | $2.2M | 3.7% | Plan not stated | SEC |
| Feb 1, 2022 | Slaine Mason P | Director | Form 4 sale | 50,000 | $1.3M | 3.0% | Plan not stated | SEC |
| Jan 26, 2022 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $78k | 1.4% | Plan not stated | SEC |
| Jan 26, 2022 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $1.9M | 3.0% | Plan not stated | SEC |
| Jan 20, 2022 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 5,000 | $138k | 1.2% | Plan not stated | SEC |
| Jan 18, 2022 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 5,000 | $137k | 2.2% | Plan not stated | SEC |
| Jan 3, 2022 | Slaine Mason P | Director | Form 4 sale | 50,000 | $1.4M | 3.0% | Plan not stated | SEC |
| Dec 27, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $88k | 1.3% | Plan not stated | SEC |
| Dec 23, 2021 | Cashman James E III | Director | Form 4 sale | 25,111 | $733k | 5.4% | Plan not stated | SEC |
| Dec 22, 2021 | Cashman James E III | Director | Form 4 sale | 19,889 | $577k | 4.1% | Plan not stated | SEC |
| Dec 22, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2.1M | 2.9% | Plan not stated | SEC |
| Dec 20, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 7,500 | $210k | 2.9% | Plan not stated | SEC |
| Dec 17, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 5,000 | $131k | 1.9% | Plan not stated | SEC |
| Dec 13, 2021 | Name not stated | Director | Form 4 sale | 50,000 | $1.4M | 2.9% | Plan not stated | SEC |
| Dec 7, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 70,000 | $1.9M | 2.6% | Plan not stated | SEC |
| Dec 3, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 70,000 | $1.8M | 2.6% | Plan not stated | SEC |
| Nov 24, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 145,000 | $4.1M | 5.1% | Plan not stated | SEC |
| Nov 22, 2021 | Slaine Mason P | Director | Form 4 sale | 376,149 | $11.2M | 17.8% | Plan not stated | SEC |
| Nov 22, 2021 | EQT Avatar Parent L.P. | 10% owner | Form 4 sale | 8.1M | $241M | 17.8% | Plan not stated | SEC |
| Nov 19, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 70,000 | $2.1M | 2.4% | Plan not stated | SEC |
| Nov 19, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 20,000 | $606k | 7.1% | Plan not stated | SEC |
| Nov 15, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,666 | $2.5M | 11.8% | Plan not stated | SEC |
| Nov 15, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 73,000 | $2.8M | 24.5% | Unusual | SEC |
| Nov 11, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 21,554 | $853k | 7.2% | Plan not stated | SEC |
| Oct 27, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2.9M | 2.5% | Plan not stated | SEC |
| Oct 26, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $120k | 1.0% | Plan not stated | SEC |
| Oct 26, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 3,000 | $120k | 0.7% | Plan not stated | SEC |
| Oct 21, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 6,116 | $236k | 1.5% | Plan not stated | SEC |
| Oct 20, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 12,674 | $489k | 3.0% | Plan not stated | SEC |
| Oct 19, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 20,000 | $762k | 6.6% | Plan not stated | SEC |
| Oct 19, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 1,210 | $47k | 0.3% | Plan not stated | SEC |
| Oct 18, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,667 | $2.4M | 10.6% | Plan not stated | SEC |
| Oct 15, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 5,000 | $187k | 1.6% | Plan not stated | SEC |
| Oct 15, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 5,000 | $187k | 1.2% | Plan not stated | SEC |
| Oct 1, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 19,354 | $649k | 6.1% | Plan not stated | SEC |
| Sep 27, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 3,000 | $108k | 0.7% | Plan not stated | SEC |
| Sep 27, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $108k | 1.0% | Plan not stated | SEC |
| Sep 22, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2.7M | 2.4% | Plan not stated | SEC |
| Sep 20, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,667 | $2.3M | 9.6% | Plan not stated | SEC |
| Sep 17, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 20,000 | $715k | 6.2% | Plan not stated | SEC |
| Sep 13, 2021 | Slaine Mason P | Director | Form 4 sale | 620,668 | $18.5M | 22.7% | Plan not stated | SEC |
| Sep 13, 2021 | EQT Avatar Parent L.P. | 10% owner | Form 4 sale | 13.4M | $399M | 22.7% | Plan not stated | SEC |
| Sep 9, 2021 | Pedersen Leif E | PRESIDENT, SOFTWARE | Form 4 sale | 51,223 | $1.8M | 18.3% | Plan not stated | SEC |
| Sep 2, 2021 | Rayner Craig R. | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 54,462 | $2M | 14.7% | Plan not stated | SEC |
| Sep 1, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 19,354 | $654k | 5.7% | Plan not stated | SEC |
| Sep 1, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 30,000 | $1M | 8.8% | Unusual | SEC |
| Aug 30, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 9,000 | $302k | 2.0% | Plan not stated | SEC |
| Aug 25, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2.3M | 2.4% | Plan not stated | SEC |
| Aug 24, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 7,500 | $225k | 2.3% | Plan not stated | SEC |
| Aug 19, 2021 | Choe Jieun W. | CHIEF STRATEGY & MARKETING | Form 4 sale | 12,500 | $354k | 3.6% | Plan not stated | SEC |
| Aug 16, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 8,000 | $229k | 2.3% | Plan not stated | SEC |
| Aug 16, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,667 | $1.9M | 8.7% | Plan not stated | SEC |
| Aug 16, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 5,000 | $143k | 1.1% | Plan not stated | SEC |
| Aug 11, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 19,354 | $533k | 5.4% | Plan not stated | SEC |
| Aug 2, 2021 | EQT Avatar Parent GP LLC | 10% owner | Form 4 sale | 7.3M | $189M | 11.0% | Plan not stated | SEC |
| Jul 28, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2M | 2.3% | Plan not stated | SEC |
| Jul 26, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $79k | 0.9% | Plan not stated | SEC |
| Jul 19, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,667 | $1.6M | 8.0% | Plan not stated | SEC |
| Jul 1, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 19,354 | $542k | 5.1% | Plan not stated | SEC |
| Jun 28, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 3,000 | $85k | 0.8% | Plan not stated | SEC |
| Jun 24, 2021 | Traynor Richard M. | SVP AND GENERAL COUNSEL | Form 4 sale | 5,000 | $132k | 1.4% | Plan not stated | SEC |
| Jun 23, 2021 | Feehery William F | CHIEF EXECUTIVE OFFICER | Form 4 sale | 75,000 | $2M | 2.3% | Plan not stated | SEC |
| Jun 22, 2021 | Schemick Michael Andrew | CHIEF FINANCIAL OFFICER | Form 4 sale | 66,666 | $1.8M | 7.4% | Plan not stated | SEC |
| Jun 16, 2021 | Edge Justin | PRES., REGULATORY & ACCESS | Form 4 sale | 5,000 | $135k | 1.1% | Plan not stated | SEC |
| Jun 14, 2021 | Aspbury Robert | PRESIDENT, SIMCYP | Form 4 sale | 19,354 | $534k | 4.9% | Plan not stated | SEC |
| Jun 11, 2021 | Rayner Craig R. | PRESIDENT, INTEGRATED DRUG DEV | Form 4 sale | 108,924 | $2.8M | 22.7% | Plan not stated | SEC |
| Mar 29, 2021 | EQT Avatar Parent L.P. | 10% owner | Form 4 sale | 8.7M | $209M | 11.6% | Plan not stated | SEC |
| Dec 15, 2020 | EQT Avatar Parent GP LLC | 10% owner | Form 4 sale | 14.2M | $306M | 15.9% | Plan not stated | SEC |